Expanding Rapid Ascertainment Network of Schizophrenia Families in Taiwan
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This proposal responds to Request for Applications RFA-MH-08-131, which seeks applications that propose to enrich pre-existing resources for schizophrenia in the National Institute of Mental Health (NIMH) Human Genetics Initiative and to apply genomic methods to further the investigators understanding of the molecular etiology of the disorder. The overarching aims of this proposal are to quickly and cost-effectively ascertain a large sample of trio families affected by schizophrenia, and to discover causal variants for the disorder in the first family-based genome-wide association study (GWAS) of the disorder. In Taiwan, there is no such kind of policy to support this kind of GWAS study as it is a very expensive study, including collecting large family samples and genome-wide single-nucleotide polymorphism (SNP) scanning. The investigators, thus, collaborate with Professor Ming T, Tsuang and his entended subcontracted researchers to apply for this project. The investigators, the research team in Taiwan, will collect 3800 trio families (11400 subjects) of schizophrenia. Through additional ascertainment within this framework, the investigators will collect an aggregate sample with adequate power for detecting in a GWAS those variants that make even small contributions to the risk for the disorder.
The investigators will meet the overarching goals of this project by accomplishing several Specific Aims, as follows: 1) Rapidly ascertain schizophrenia trio families from Taiwanese clinical ascertainment sites; 2) Supplement NIMH Genetics Initiative collections by sending all clinical data and biomaterials to the appropriate repositories; 3) Assess the association of schizophrenia with a genome-wide panel of single-nucleotide polymorphisms (SNPs) and their constituent haplotypes; 4) Analyze quantitative schizophrenia phenotypes such as age at onset ; 5) Perform a genome-wide survey for copy-number variations related to schizophrenia; 6) Test for gene-gene interactions (epistasis); and 7) Test for gene-environment interactions, such as the well-established effect of season of birth.
| Condition | Intervention |
|---|---|
|
Schizophrenia |
Other: No intervention would be provided in this research |
| Study Type: | Observational |
| Study Design: | Observational Model: Family-Based |
| Official Title: | Expanding Rapid Ascertainment Network of Schizophrenia Families in Taiwan |
| Estimated Enrollment: | 600 |
| Study Start Date: | October 2010 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Schizophrenia Family |
Other: No intervention would be provided in this research
No intervention would be provided in this research,but need to draw blood
|
Eligibility| Ages Eligible for Study: | 16 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Schizophrenia patients and their biological parents
Inclusion Criteria:
- clinical diagnosis of schizophrenia and their parents, and parents are still alive
Exclusion Criteria:
- person with Mental Retardation
- persons with epilepsy
- alcohol or substance abuse combined
- in combination with other organic brain damage syndrome
Contacts and Locations| Contact: Hai-Gwo Hwu | 886-2-23122453 ext 66785 | haigohwu@ntu.edu.tw |
| Taiwan | |
| China Medical University Hospital | Recruiting |
| Taichung, Taiwan | |
| Contact: Hsien-Yuan Lane | |
| Study Director: | Hsien-Yuan Lane | China Medical University Hospital |
More Information
No publications provided
| Responsible Party: | Hsien-Yuan Lane,Chief of Psychiatry Department, China Medical University Hospital |
| ClinicalTrials.gov Identifier: | NCT01249079 History of Changes |
| Other Study ID Numbers: | DMR99-IRB-214 |
| Study First Received: | November 24, 2010 |
| Last Updated: | November 30, 2010 |
| Health Authority: | Taiwan: Department of Health |
Additional relevant MeSH terms:
|
Schizophrenia Schizophrenia and Disorders with Psychotic Features Mental Disorders |
ClinicalTrials.gov processed this record on May 21, 2013